MAY 21, 2019 7:00 AM PDT

Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function

Speaker
  • Postdoctoral Fellow, Department of Microbiology and Immunology, University of California, San Francisco
    Biography
      Eric Shifrut is a postdoctoral fellow in Alexander Marson's group at the University of California, San Francisco. Eric completed his PhD at the Weizmann Institute of Science in Israel, under supervision of Prof. Nir Friedman. In his thesis work, Eric developed computational and experimental platforms to map the landscape of T cell receptor repertoires in health and disease. Since joining the Marson lab in 2016, Eric has been working to pioneer CRISPR applications in primary human T cells. These efforts aim to design discovery platforms to explore and exploit genetic circuits to boost T cell function in cancer immunotherapy.

    Abstract
    DATE:  May 21, 2019
    TIMEL  7:00am PT, 10:00am ET
     
    Human T cells are central effectors of immunity and cancer immunotherapy. CRISPR-based functional studies in T cells could prioritize novel targets for drug development and improve the design of genetically reprogrammed cell-based therapies. However, large-scale CRISPR screens have been challenging in primary human cells. Critical biology of human immune cells, including key signaling pathways and effector functions, may not be recapitulated in immortalized cell lines. We developed a new method, sgRNA lentiviral infection with Cas9 protein electroporation (SLICE), to identify regulators of stimulation responses in primary human T cells. Genome-wide loss-of-function screens identified essential T cell receptor signaling components and genes that negatively tune proliferation following stimulation. Targeted ablation of individual candidate genes characterized hits and identified perturbations that enhanced cancer cell killing. SLICE coupled with single-cell RNA-Seq revealed signature stimulation-response gene programs altered by key genetic perturbations. SLICE genome-wide screening was also adaptable to identify mediators of immunosuppression, revealing genes controlling responses to adenosine signaling. In summary, we have developed a novel pooled CRISPR screening technology with the potential to explore unmapped genetic circuits in primary human cells and to guide the design of engineered cell therapies.
     
    Learning Objectives:
    • Identify the components of a new pooled CRISPR screening technique (SLICE) using molecular biology
    • Understand how to explore unmapped genetic circuits in primary human cells using SLICE
    • Learn how to design engineered cell therapies using SLICE
     
     
     
     
    Webinars will be available for unlimited on-demand viewing after live event.
     
    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

    Show Resources
    You May Also Like
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    MAY 21, 2019 7:00 AM PDT

    Genome-wide CRISPR Screens in Primary Human T Cells Reveal Key Regulators of Immune Function


    Specialty

    Molecular Biology

    Immunology

    Cancer Research

    Genetics

    Cell Biology

    Biotechnology

    Molecular Diagnostics

    Genomics

    Cell Culture

    Gene Expression

    Biomarkers

    Microbiology

    Dna

    Clinical Research

    Cancer Therapeutics

    Geography

    North America56%

    Europe23%

    Asia12%

    South America5%

    Africa3%

    Oceania1%

    Registration Source

    Website Visitors44%

    Email Promotions41%

    WAVE Newsletter Promotion9%

    Trending Newsletter Promotion2%

    Client/Sponsor Promotions1%

    Social Media Promotions1%

    Exhibitor Promotions1%

    Other1%

    Job Title

    Research Scientist17%

    Student14%

    Educator/Faculty10%

    Scientist10%

    Medical Laboratory Technician9%

    Executive8%

    Post Doc8%

    Clinical Laboratory Scientist7%

    Medical Doctor/Specialist5%

    Facility/Department Manager5%

    Lab Management4%

    Biologist3%

    Organization

    Academic Institution30%

    Biotech Company11%

    Hospital10%

    Research Institute8%

    Clinical Laboratory6%

    Pharmaceutical Company5%

    Medical School3%

    Life Science Company3%

    Government3%

    Medical Center2%

    Non-Profit Organization2%

    Consultant2%

    Contract Research Organization (Cro)1%

    Medical Device Company1%

    Other4%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more